December 4th 2024
A statistical procedure based on a quality range is proposed for demonstrating comparability between pre-change and post-change process slopes in an accelerated or stressed stability study.
NGS abbreviates drug discovery timelines.
Addressing the Analytical Challenge of Meeting Quick Turnaround Times (AAPS PharmSci 360)
November 2nd 2023Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, discusses ways that labs are addressing the pressure of rapid analytical turnaround times.